Study Stopped
insufficient enrollment
Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema
A Randomized Controlled Study of Early Mini-invasive Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusions or Pleural Empyema - ESMITE (European Study on Mini-invasive Thoracoscopy in Empyema)
1 other identifier
interventional
2
3 countries
5
Brief Summary
Multicenter, randomized controlled study to compare early mini-invasive thoracoscopy to simple chest tube drainage in complicated parapneumonic effusions or pleural empyema. 100 patients will be recruited. Follow-up will be 3 months. It will be looked at the rate medical cure, the need for secondary interventions, death and duration of hospital stay. In a nested trial in 20 patients the intrapleural pharmacokinetics of linezolid (approved antibiotic agent) will be measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Oct 2005
Shorter than P25 for phase_3
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 5, 2005
CompletedFirst Posted
Study publicly available on registry
October 6, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2007
CompletedMay 24, 2016
May 1, 2016
1.3 years
October 5, 2005
May 23, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medical cure without secondary Intervention
Death
Secondary Outcomes (7)
Duration of hospital stay
Radiological outcome
Duration of drainage
Total amount of drainage fluid
Estimated cost
- +2 more secondary outcomes
Study Arms (2)
Medical thoracoscopy
EXPERIMENTALSimple chest tube drainage
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Septated pleural effusion (ultrasonography) in the context of a lower respiratory tract infection
- Frank pleural empyema (pus)
You may not qualify if:
- Fibrothorax
- Tuberculous empyema
- Medical thoracoscopy cannot be performed within 24 hours
- Pregnancy
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- Lancardis Foundationcollaborator
- Pfizercollaborator
Study Sites (5)
Department of Pneumology, University Hospital of Alexandroupolis
Alexandroupoli, 68100, Greece
Pulmonology Unit, Spedali Civili di Brescia
Brescia, 25103, Italy
UO Pneumologia
Imperia, 18100, Italy
Pulmonology and Thoracic Endoscopy Unit Azienda Ospedaliera di Parma
Parma, 43100, Italy
Centre Valaisan de Pneumologie
Crans-Montana, CH-3963, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin H Brutsche, MD, Prof.
Pneumology, Kantonsspital St. Gallen
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2005
First Posted
October 6, 2005
Study Start
October 1, 2005
Primary Completion
January 1, 2007
Study Completion
January 1, 2007
Last Updated
May 24, 2016
Record last verified: 2016-05